Abstract:Tumor-infiltrating lymphocytes (TIL) that can recognize and kill tumor cells have curative potential in subsets of patients treated with adoptive cell transfer (ACT). However, lack of TIL therapeutic efficacy in many patients may be due in large part to a paucity of tumor-reactive T cells in TIL and the exhausted and terminally differentiated status of those tumor-reactive T cells. We sought to reprogram exhausted TIL that possess T-cell receptors (TCR) specific for tumor antigens into induced pluripotent stem cells (iPSC) to rejuvenate them for more potent ACT. We first attempted to reprogram tumor neoantigen-specific TIL by αCD3 Ab prestimulation which resulted in failure of establishing tumor-reactive TIL-iPSCs, instead, T cell-derived iPSCs from bystander T cells were established. To selectively activate and enrich tumor-reactive T cells from the heterogenous TIL population, CD8+ PD-1+ 4-1BB+ TIL population were isolated after coculture with autologous tumor cells, followed by direct reprogramming into iPSCs. TCR sequencing analysis of the resulting iPSC clones revealed that reprogrammed TIL-iPSCs encoded TCRs that were identical to the pre-identified tumor-reactive TCRs found in minimally cultured TIL. Moreover, reprogrammed TIL-iPSCs contained rare tumor antigen-specific TCRs, which were not detectable by TCR sequencing of the starting cell population. Thus, reprogramming of PD-1+ 4-1BB+ TIL after coculture with autologous tumor cells selectively generates tumor antigen-specific TIL-iPSCs, and is a distinctive method to enrich and identify tumor antigen-specific TCRs of low frequency from TIL. Significance: Reprogramming of TIL into iPSC holds great promise for the future treatment of cancer due to their rejuvenated nature and the retention of tumor-specific TCRs. One limitation is the lack of selective and efficient methods for reprogramming tumor-specific T cells from polyclonal TIL. Here we addressed this limitation and present a method to efficiently reprogram TIL into iPSC colonies carrying diverse tumor antigen reactive TCR recombination.

A Protocol for Generating Induced T Cells by Reprogramming B Cells in Vivo

A Protocol to Develop T Helper and Treg Cells in Vivo

Incorporating protein transduction domains (PTD) within recombinant ‘fusion’ transcription factors. A novel strategy for directing stem cell differentiation?

Potential Utility of Cell-Permeable Transcription Factors to Direct Stem Cell Differentiation

Advances in Reprogramming of Peripheral Blood Cells to Induced Pluripotent Stem Cells

Protocol for in vitro induction and characterization of murine B cell-induced CD4+ regulatory T cells

Transcription Factor Hoxb5 Reprograms B Cells into Functional T Lymphocytes.

Retroviral CRISPR/Cas9-Mediated Gene Targeting for the Study of Th17 Differentiation in Vitro

Reprogramming Committed Murine Blood Cells to Induced Hematopoietic Stem Cells with Defined Factors

Reprogramming of somatic cells via TAT-mediated protein transduction of recombinant factors.

Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins.

Understanding and Modulating Immunity With Cell Reprogramming

Reprogramming of Tumor-reactive Tumor-infiltrating Lymphocytes to Human-induced Pluripotent Stem Cells

Using Small Molecules to Improve Generation of Induced Pluripotent Stem Cells from Somatic Cells

Programming of Regulatory T Cells from Pluripotent Stem Cells and Prevention of Autoimmunity.

Generation of Human iPSCs by Protein Reprogramming and Stimulation of TLR3 Signaling

Efficient generation of induced pluripotent stem cell lines from peripheral blood mononuclear cells

Rapid de novo generation of antigen specific human B cells with expression of Blimp‐1 and AID by in vitro immunization

Generation and clinical potential of functional T lymphocytes from gene-edited pluripotent stem cells

A Combined Chemical and Genetic Approach for the Generation of Induced Pluripotent Stem Cells

Protocol for in Vitro Generating Innate Lymphoid Cells from Mouse Α4β7+ Lymphoid Progenitors